Tuberculin Skin Testing: What Is It? Classification of The Tuberculin Skin Test Reaction
Tuberculin Skin Testing: What Is It? Classification of The Tuberculin Skin Test Reaction
Tuberculin Skin Testing: What Is It? Classification of The Tuberculin Skin Test Reaction
How Are TST Reactions Interpreted? » People with certain medical conditions that place
them at high risk for TB (e.g., silicosis, diabetes
Skin test interpretation depends on two factors: mellitus, severe kidney disease, certain types
of cancer, and certain intestinal conditions)
• Measurement in millimeters of the induration
» People with a low body weight
• Person’s risk of TB infection or the risk of progression
(<90% of ideal body weight)
to TB disease if infected
» Children younger than 5 years of age
» Infants, children, and adolescents exposed
to adults in high-risk categories
• An induration of 15 or more millimeters is considered
positive in
Most persons can receive a TST. TST is the recommended • Either on the same day as vaccination with live-virus
method of testing for children younger than 5 years of vaccine or
age. It should be noted that the American Academy of
• At least 1 month after the administration of the live-virus
Pediatrics (AAP) recommends that either a TST or TB
vaccine
blood test (interferon-gamma release assay [IGRA]), can be
used in children 2 years and older. In children previously
vaccinated with BCG, a TB blood test is preferred to
avoid a false-positive TST result caused by a previous
vaccination with BCG.
TST is contraindicated only for persons who have had a
severe reaction (e.g., necrosis, blistering, anaphylactic
shock, or ulcerations) to a previous TST. It is not
contraindicated for any other persons, including infants,
children, pregnant women, or persons living with HIV.
However, TB blood tests are the preferred method of testing
for people who have received the BCG TB vaccine.
Are there alternative tests to the TST? What are treatment options for latent
There are two kinds of tests that are used to determine if
a person has been infected with TB bacteria: the TB blood
TB infection?
test and the TB skin test. TB blood tests (sometimes called Treating latent TB infection is effective in preventing TB disease
IGRAs) use a blood sample to find TB infection. The tests and less costly than treating TB disease. There are several
measure the response of TB proteins when they are mixed treatment regimens for the treatment of latent TB infection.
with a small amount of blood. Only one visit is required to These regimens use the drugs isoniazid, rifapentine, or
draw blood for this test. Health care providers are encouraged rifampin.
to use newer TB blood tests to screen for TB infection. In CDC and the National Tuberculosis Controllers Association
order to prevent false-positive reactions, TB blood tests are (NTCA) preferentially recommend short-course, rifamycin-
also the preferred method of TB testing for people 5 years of based, 3- or 4-month latent TB infection treatment regimens
age and older who have received the BCG TB vaccine. over 6- or 9-month isoniazid monotherapy (6H or 9H,
respectively). Short-course regimens include: Three months
What does a positive TST mean for the of once-weekly isoniazid plus rifapentine (3HP), four months
of daily rifampin (4R), or three months of daily isoniazid plus
diagnosis of latent TB infection and TB rifampin (3HR). Short-course latent TB infection treatments
are effective, are safe, and have higher completion rates than
disease? longer treatments.
If a short-course treatment regimen is not an option, 6H or 9H
Diagnosis of Latent TB Infection is an effective alternative latent TB infection treatment regimen.
A diagnosis of latent TB infection is made if a person has
a positive TB test result and a medical evaluation does
not indicate TB disease. The decision about treatment for
latent TB infection will be based on a person’s chances of
developing TB disease by considering their risk factors.
Diagnosis of TB Disease
TB disease is diagnosed by medical history, physical
examination, chest x-ray, and other laboratory tests. TB
disease is treated by taking several drugs as recommended
by a health care provider.
Additional Information
• CDC. Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings, 2005. MMWR
2005; 54 (No. RR-17). www.cdc.gov/tb/publications/guidelines/infectioncontrol.html
• CDC. Mantoux Tuberculin Skin Test: Training Materials Kit (2003).
• CDC. Targeted tuberculin testing and treatment of latent tuberculosis infection. MMWR 2000; 49 (No. RR-6). www.cdc.
gov/MMWR/PDF/rr/rr4906.pdf
• Lewinsohn et al., Official American Thoracic Society/Infectious Diseases Society of America/CDC Clinical Practice
Guidelines: Diagnosis of Tuberculosis in Adults and Children, Clinical Infectious Diseases, 2017, Pages e1–e33. www.
academic.oup.com/cid/article/64/2/e1/2629583
• Latent TB Infection Testing and Treatment: Summary of U.S. Recommendations www.cdc.gov/tb/publications/ltbi/pdf/
CDC-USPSTF-LTBI-Testing-Treatment-Recommendations-508.pdf
• What You Need To Know About the Tuberculosis Skin Test www.cdc.gov/tb/publications/pamphlets/tb_skin_test.pdf
@CDC_TB CDCTB